RARRES2P9

Across TCGA pan-cancer cohorts, RARRES2P9 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated RARRES2P9 data layer.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher RARRES2P9 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RARRES2P9 expression acts as an unfavorable survival marker.

LUSC, STAD, and THYM are the cancer types where RARRES2P9 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	OS	Tertile	III,IV	0.277	0.715	<.001	111	view →
STAD	DFS	Tertile	All	0.470	0.660	.003	72	view →
THYM	OS	Tertile	All	0.186	0.880	<.001	72	view →
COAD	DFS	Tertile	IV	0.159	0.503	.006	57	view →
ESCA	OS	Tertile	All	0.198	0.872	.003	36	view →
CESC	OS	Tertile	All	0.105	0.587	.019	36	view →
KICH	OS	Tertile	III,IV	0.178	0.847	<.001	30	view →
KIRP	DFS	Tertile	II,III,IV	0.417	0.776	.015	21	view →
KIRC	DFS	Tertile	IV	0.221	0.603	.046	18	view →
BLCA	DFS	Tertile	IV	0.145	0.475	.014	18	view →
UVM	OS	Tertile	All	0.248	0.769	.007	18	view →
LUAD	DFS	Tertile	IV	0.342	0.893	<.001	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

RARRES2P9–LUSC (OS)

Open the LUSC breakdown →